Aadi bioscience announces presentations at the 2023 american society of clinical oncology (asco) annual meeting

Los angeles , may 25, 2023 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mtor pathway genes, today announced poster presentations at the 2023 asco annual meeting taking place june 2-6, 2023, in chicago, il. the abstracts associated with the poster presentations are now available on the asco meeting website.
AADI Ratings Summary
AADI Quant Ranking